Central Laboratories Solutions
-
Intelligent Trials - Diversity
2/17/2023
Medidata AI’s Intelligent Trials solution provides insights that allow you to take action to improve study diversity during the planning stages.
-
Leverage AI To Optimize Protocol Design & Study Start-Up
9/26/2024
Citeline SmartSolutions is an integrated suite of solutions that optimizes and accelerates clinical trial planning and site selection. These AI-enabled technology products help study sponsors reduce costly protocol amendments and increase predictability.
-
RWD & Human Insight From Consulting & Analytics
12/3/2024
Citeline’s Consulting & Analytics team helps clinical trials harness the power of real-world data (RWD) by transforming raw numbers into actionable insights.
-
Site Cloud: End Of Study (EOS)
1/2/2023
Site Cloud: End of Study is the first end-to-end solution that seamlessly generates, distributes & manages sites’ study files at the end of a study. With EOS, sites’ study files are accessible and downloadable via a secure and trusted unified platform, eliminating the need to create and distribute physical media and deal with paper acknowledgment forms.
-
Oncology Solutions
1/20/2025
Explore how this platform of oncology solutions integrates advanced technologies to streamline oncology trials, enhancing efficiency, patient engagement, regulatory compliance, and data accuracy.
-
Drive Automation And Efficiency In Your Interim Lock Process
10/11/2024
Medidata Interim Lock enhances automation and efficiency in managing clinical study databases by streamlining the interim lock process.
-
A New Blueprint For Transforming Feasibility And Recruitment
10/20/2025
Clinical trials often fail due to poor feasibility planning. A new AI-powered approach bridges protocol design with real-world patient access to improve enrollment success.
-
Modernizing Clinical Research Through Digital Transformation
2/7/2025
Facilitate continuous, high-precision patient-centered data collection with a transformative digital health solution that enhances clinical research through its unified software and data ecosystem.
-
Balancing Compliance Among The Shifting Sands Of Pharmaceutical Data Privacy Regulations
8/26/2022
Maximize compliance, increase revenue potential, and improve patient safety by leveraging proven technology.
-
Glioblastoma Multiforme
11/15/2022
Medidata AI’s Synthetic Control Arm® (SCA®) leverages historical clinical trial data (HCTD) to provide a more relevant clinical insight for the purpose of developing new therapies.